GCK and retinal disorder: However, clinicians would probably consider treatment initiation in some GCK-MODY individuals, especially in patients with relatively common nonproliferative retinopathy, those with HbA1c >7.0% (53.0 mmol/mol) and/or “overlapping” type 2 diabetes.